Description

How to use:

Morning:

Step 1 – Obagi Nu-Derm Gentle Cleanser: use in morning and evening to damp face and neck with moistened fingertips. Rinse completely with warm water.

Step 2 – Obagi Nu-Derm Toner: Apply twice a day after cleansing. Saturate cotton pad and wipe gently over face and neck. Avoid the eyelid area. Do not rinse off.

Step 3 – Obagi Nu-Derm Clear Fx: Measure ½ to 1 gram (approximately 1 to 2 pea-size drops) and apply evenly to the entire face twice daily or as directed by your physician. Avoid contact with the eyes.

Step 4 – Obagi Nu-Derm Exfoderm: Apply to face in the morning following the application of Obagi Nu-Derm Clear or as directed by your physician.

Step 5 –Obagi Nu-Derm Blender: A thin application should be applied to the affected area in the morning and evening or as directed by a physician.

step 6 – Obagi Hydrate Facial Moisturizer: Apply a thin layer to the face twice daily or as directed by a physician.

Step 7 – Obagi Nu-Derm Sun Shield SPF 50: Apply liberally 30 minutes before sun exposure and reapply as needed every two to three hours or after towel drying, swimming or perspiring. For use on children younger than six months, consult a physician.

Evening:

Step 1 –

Obagi Nu-Derm Gentle Cleanser: use in morning and evening to damp face and neck with moistened fingertips. Rinse completely with warm water.

Step 2 – Obagi Nu-Derm Toner: Apply twice a day after cleansing. Saturate cotton pad and wipe gently over face and neck. Avoid the eyelid area. Do not rinse off.

Step 3 – Obagi Nu-Derm Clear Fx: Measure ½ to 1 gram (approximately 1 to 2 pea-size drops) and apply evenly to the entire face twice daily or as directed by your physician. Avoid contact with the eyes.

Step 4 – Obagi Nu-Derm Blender: Use this product in the evening mixed with your tretinoin (cream or gel). Measure ½ to 1 gram (approximately 1 to 2 pea-size drops) and apply evenly to the entire face, avoiding the eyelid area. Massage until completely absorbed.

Step 5 – Obagi Hydrate Facial Moisturizer: Apply a thin layer to the face twice daily or as directed by a physician.

(CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS): Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.)